Shuttle Pharmaceuticals (NASDAQ:SHPH) Shares Down 0.7% – What’s Next?

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) shares traded down 0.7% on Wednesday . The company traded as low as $0.61 and last traded at $0.61. 40,294 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 433,445 shares. The stock had previously closed at $0.62.

Shuttle Pharmaceuticals Stock Down 5.9 %

The business’s 50 day simple moving average is $1.05. The stock has a market capitalization of $2.35 million, a PE ratio of -0.15 and a beta of -1.70.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .